PuREC Co.Ltd.
The startup develops a culture technology that focuses on rapidly changing cell therapies and mesenchymal stem cells for treating hypophosphatasia, a rare bone-formation deficiency in newborns, and spinal canal stenosis due to disc herniation. This technology enhances treatment efficacy for these specific medical conditions, providing targeted therapeutic solutions.
- Biotechnology
Updated 6 months ago
Funding
Raised to date
$11.9MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops a culture technology that focuses on rapidly changing cell therapies and mesenchymal stem cells for treating hypophosphatasia, a rare bone-formation deficiency in newborns, and spinal canal stenosis due to disc herniation. This technology enhances treatment efficacy for these specific medical conditions, providing targeted therapeutic solutions.